WHO ICTRP trial
Onderzoek naar kwaliteit van leven en zorggebruik bij gevorderde prostaat kanker
NL-OMON27164 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON27164 |
|---|---|
| Public title | Onderzoek naar kwaliteit van leven en zorggebruik bij gevorderde prostaat kanker |
| Scientific title | Patient Reported Outcomes in the Castration-resistant Prostate cancer RegIstry |
| Primary sponsor | sponsor Erasmus University Rotterdam, Institute for Medical Technology Assessment address PO Box 1738 postal code 3000 DR city Rotterdam country The Netherlands phone +31 10 408 8696 fax email [email protected] |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Conditions | Castration-resistant prostate cancer |
| Interventions | Repeated HRQOL and cost assessment by questionnaires (EQ-5D, QLQ-C30, QLQ-PR25, BPI-SF and a selection of iMTA cost questionnaires every three months, starting at baseline. |
| Registration date | Jul 30, 2013 |
| Target size | 200 |
| Secondary IDs | NL3934;NTR4096;NL44602.029.13;ISRCTN wordt niet meer aangevraagd. |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: